Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 6Lymphoid 5Tumor-Agnostic 4Breast 4Head & Neck 3Thoracic 2Plasma cell 2Other 2Genitourinary 2Sarcoma 1Other solid neoplasm 1Other hematologic neoplasm 1Endocrine 1

Conditions

Lung Neoplasms 1Head and Neck Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 510Cisplatin 410Pemetrexed 400Radiotherapy 285Docetaxel 244Paclitaxel 227pembrolizumab 226Gemcitabine 198Drug Therapy 191Bevacizumab 190Erlotinib Hydrochloride 189Radiosurgery 177Nivolumab 168Etoposide 155durvalumab 154osimertinib 126atezolizumab 109Gefitinib 96Blood Specimen Collection 93Magnetic Resonance Spectroscopy 91Vinorelbine 90anlotinib 88Surgical Procedures, Operative 85Ipilimumab 62Immunotherapy 62Surveys and Questionnaires 60sintilimab 59Specimen Handling 59tislelizumab 58Irinotecan 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Glutamine × Thoracic × Clear all
NCT05852990 2026-04-09

Glutamine Plus L. Reuteri Prevents TKI Therapy-diarrhea in Patients With NSCLC

Instituto Nacional de Cancerologia de Mexico

Phase 3 Recruiting
28 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05054517 2021-09-23

Oral Glutamine and Thoracic/Upper Aerodigestive Tumors Radiation Toxicity

National and Kapodistrian University of Athens

Completed
72 enrolled
Head & NeckThoracic

Head and Neck Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡